Arif Dönmez

Arif Dönmez

Auto-generated profile, based on publicly available information

Arif Dönmez

IUF – Leibniz Research Institute for Environmental Medicine Düsseldorf Germany

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2005 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
ADArif Dönmez
Arif Dönmez
MKM. Zeki Karagülle
M. Zeki Karagülle
NTNuran Tercan
Nuran Tercan
MDMustafa Dinler
Mustafa Dinler
HIHalim İşSever
Halim İşSever
MTMustafa Turan
Mustafa Turan

2 April 2011 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
SÖSeçil Özkurt
Seçil Özkurt
ADArif Dönmez
Arif Dönmez
MKM. Zeki Karagülle
M. Zeki Karagülle
EUEmel Uzunoğlu
Emel Uzunoğlu
MTMustafa Turan
Mustafa Turan
NENergis Erdoğan
Nergis Erdoğan

28 April 2015 in International Journal of Biometeorology
Verified
Journal Article
Closed access
PDF file
ABAli Osman Bağdatlı
Ali Osman Bağdatlı
ADArif Donmez
Arif Donmez
RERıza Eröksüz
Rıza Eröksüz
GBGüler Bahadır
Güler Bahadır
MTMustafa Turan
Mustafa Turan
NENergis Erdoğan
Nergis Erdoğan

4 December 2019 in International Journal of Biometeorology
Verified
Journal Article
Closed access
PDF file
RERıza Eröksüz
Rıza Eröksüz
FFFatma Begüm Erol Forestier
Fatma Begüm Erol Forestier
FKFatih Karaaslan
Fatih Karaaslan
RFRomain Forestier
Romain Forestier
HIHalim İşsever
Halim İşsever
ADArif Dönmez
Arif Dönmez

14 April 2026 in Advanced Science
Verified
Journal Article
Open access
EKEliska Kuchovska
Eliska Kuchovska
KBKristina Bartmann
Kristina Bartmann
GRGeorgea Raad
Georgea Raad
MSMats Schade
Mats Schade
LLLuiz Carlos Maia Ladeira
Luiz Carlos Maia Ladeira
EFEllen Fritsche
Ellen Fritsche
The Developmental Neurotoxicity (DNT) in vitro battery (IVB) enables efficient and human‐relevant evaluation of chemicals for DNT potential. To expand its biological applicability domain toward human disease, this study maps neurodevelopmental disorder (NDD)‐relevant signaling pathways to key neurodevelopmental processes (KNDPs) using primary human fetal neural progenitor cells (NPCs). Using pharmacological intervention, eighteen NDD pathways are assessed for their impact on seven KNDPs, namely NPC proliferation, radial glia migration, neuronal and oligodendrocyte differentiation and migration, and neurite outgrowth. In total, modulation of sixteen pathways is associated with changes in at least one KNDP. Oligodendrocyte differentiation shows the highest sensitivity (13 pathways), followed by radial glia migration (11 pathways) and NPC proliferation (9 pathways), whereas neuronal migration remains unaffected. Perturbation of the RhoA and mitochondrial complex I pathways is associated with the broadest phenotypic responses, influencing five KNDPs each, while STAT3‐ and TrkB‐related modulation falls outside the assay's applicability domain. Pathway‐KNDP associations are integrated into an exemplary interactive physiological map of human oligodendrocyte development, linking mechanistic perturbations to human‐relevant biology. Defining which NDD pathways can be functionally probed refines the DNT IVB's biological applicability domain, increases confidence in its protective power, and supports mechanistic interpretation of new approach methodology‐based DNT assessment.

21 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
HKHagen Eike Keßel
Hagen Eike Keßel
SMStefan Masjosthusmann
Stefan Masjosthusmann
KBKristina Bartmann
Kristina Bartmann
JBJonathan Blum
Jonathan Blum
ADArif Dönmez
Arif Dönmez
EFEllen Fritsche
Ellen Fritsche
In the field of hazard assessment, Benchmark concentrations (BMC) and their associated uncertainty are of particular interest for regulatory decision making. The BMC estimation consists of various statistical decisions to be made, which depend largely on factors such as experimental design and assay endpoint features. In current data practice, the experimenter is often responsible for the data analysis and therefore relies on statistical software without being aware about the software default settings and how they can impact the outputs of data analysis. To provide more insight into how statistical decision making can influence the outcomes of data analysis and interpretation, we have used case studies on a large dataset produced by a developmental neurotoxicity (DNT) in vitro battery (DNT IVB). Here we focused on the BMC and its confidence interval (CI) estimation, as well as on the final hazard classification. We identified five crucial statistical decisions experimenter have to face during data analysis: choice of replicate averaging, response data normalization, regression modelling, BMC and CI estimation, as well as choice of benchmark response levels. In addition, the strength of our data evaluation platform is the integration of endpoint-specific hazard classifications, including flagging systems for uncertain cases, which none of the so far existing statistical data analysis platforms provide. The insights gained in this study demonstrate how important fit-for-purpose, internationally harmonized and accepted data evaluation and analysis procedures are for an objective hazard classification.